OTC FILING WATCH · LIVEOfficial-source OTC filing intelligence
AUTOMATED SEC FILING DILIGENCE BRIEF
PUBLIC-RECORD DELIVERY

Calidi Biotherapeutics, Inc.

CIK 0001855485Ticker CLDWWSEC observed OTC

Automatically organized from the issuer’s official SEC submissions index. This brief is the starting evidence layer for buyer, FA, legal and broker-dealer review—not a legal conclusion or safety rating.

Open issuer dossier
Reporting & material events78

captured official filings

Registration & offering34

captured official filings

Ownership41

captured official filings

Governance7

captured official filings

WHAT THIS AUTOMATES

One evidence index instead of a manual filing hunt.

It groups recent reporting, registration/offer, ownership and governance filings, preserves the SEC source link and keeps a reusable chronology in the issuer’s record.

PROFESSIONAL DELIVERY LAYER

What teams can pay to automate next.

Cross-version text comparison, monitored alerts, change-specific diligence questions, CSV/PDF exports and a shared deal-team brief are the professional workflow built on this public evidence layer.

MACHINE-DETECTED FILING CHANGE RADAR

Public registration text delta

Comparing S-1 filed 2025-08-15 with S-1/A filed 2024-04-15.

Earlier SEC filingLatest SEC filing
303latest comparable sentences
258new-text candidates
121prior-text candidates not found

Tracked-term count changes

Counts are navigation signals, not conclusions. Open both official filings to determine materiality.

  • shares52 → 23-29
  • control14 → 3-11
  • offering58 → 55-3
  • proceeds5 → 7+2
  • risk factor10 → 8-2
  • management8 → 6-2

Candidate disclosure excerpts

Only sentence-level additions or removals containing tracked diligence terms are shown. These are reading cues, not materiality findings.

New in latest filing
  • The assumed purchase price for each Common Stock Unit is $0.69 (equal to the last sale price of our common stock as reported by the NYSE American on April 12, 2024).The Series A Warrants, Series B Warrants, Series B-1 Warrants, the Series C Warrants and the Series C-1 Warrants will have an initial exercise price of $0.69 per sha
  • The Series A Warrants will expire five years from the closing date of this offering.
  • The Series B Warrants will expire twelve months from the closing date of this offering.
Present in earlier filing, not found in latest
  • The Common Warrants will have an initial exercise price of $5.01 per share or $5.009 per pre-funded warrant, which prices are equal to 100% of the price per Common Stock Unit and price per PFW Unit (defined below), respectively, sold in the offering.
  • The Common Warrants will expire five (5) years from the closing date of this offering.
  • We are also offering shares of our common stock or the pre-funded warrants that are issuable from time to time upon exercise of the Common Warrants.

Method: readable plain text is extracted from two official SEC HTML filings, then compared at sentence and tracked-term level. Formatting, exhibit differences and boilerplate may create false positives. This radar is not legal advice, a disclosure completeness opinion or a transaction recommendation.

DOWNLOAD EDITION

Save a project-ready issuer record.

US$29 one time. No subscription and no account. You receive the current printable Evidence Snapshot in this browser immediately after verified payment.

  • Source-linked filing chronology and registration path
  • Machine-detected amendment and tracked-term change view
  • Official-source index for project-file archiving and downloadable CSV export

Secure checkout by PayPal.

AUTOMATED EVIDENCE SNAPSHOT

Save this source-linked record

Download a printable HTML snapshot of the current public-record timeline and change view. A one-time download unlocks a saveable issuer record. Official sources remain controlling.

Unlock download · US$29
OFFICIAL SEC SUBMISSIONS

Captured filing chronology

Open Evidence Snapshot →
  1. 8-K
    Reporting & material eventsOpen SEC filing →
  2. 3
    OwnershipOpen SEC filing →
  3. 8-K
    Reporting & material eventsOpen SEC filing →
  4. 8-K
    Reporting & material eventsOpen SEC filing →
  5. 8-K
    Reporting & material eventsOpen SEC filing →
  6. 10-Q
    Reporting & material eventsOpen SEC filing →
  7. 8-K
    Reporting & material eventsOpen SEC filing →
  8. 8-K
    Reporting & material eventsOpen SEC filing →
  9. DEF 14A
    GovernanceOpen SEC filing →
  10. PRE 14A
    GovernanceOpen SEC filing →
  11. 8-K
    Reporting & material eventsOpen SEC filing →
  12. 10-K
    Reporting & material eventsOpen SEC filing →
  13. 8-K
    Reporting & material eventsOpen SEC filing →
  14. 8-K
    Reporting & material eventsOpen SEC filing →
  15. 424B5
    Registration & offeringOpen SEC filing →
  16. 424B5
    Registration & offeringOpen SEC filing →
  17. 8-K
    Reporting & material eventsOpen SEC filing →
  18. 8-K
    Reporting & material eventsOpen SEC filing →
  19. 4
    OwnershipOpen SEC filing →
  20. 10-Q
    Reporting & material eventsOpen SEC filing →
  21. 8-K
    Reporting & material eventsOpen SEC filing →
  22. 8-K
    Reporting & material eventsOpen SEC filing →
  23. 8-K
    Reporting & material eventsOpen SEC filing →
  24. 8-K
    Reporting & material eventsOpen SEC filing →
  25. 8-K
    Reporting & material eventsOpen SEC filing →
  26. 4
    OwnershipOpen SEC filing →
  27. 4
    OwnershipOpen SEC filing →
  28. 4
    OwnershipOpen SEC filing →
  29. 8-K
    Reporting & material eventsOpen SEC filing →
  30. 3
    OwnershipOpen SEC filing →
  31. 4
    OwnershipOpen SEC filing →
  32. 4
    OwnershipOpen SEC filing →
  33. 4
    OwnershipOpen SEC filing →
  34. 4
    OwnershipOpen SEC filing →
  35. 8-K
    Reporting & material eventsOpen SEC filing →
  36. 424B4
    Registration & offeringOpen SEC filing →
  37. EFFECT
    Registration & offeringOpen SEC filing →
  38. S-1
    Registration & offeringOpen SEC filing →
  39. 8-K
    Reporting & material eventsOpen SEC filing →
  40. 10-Q
    Reporting & material eventsOpen SEC filing →
  41. 8-K
    Reporting & material eventsOpen SEC filing →
  42. 8-K
    Reporting & material eventsOpen SEC filing →
  43. EFFECT
    Registration & offeringOpen SEC filing →
  44. 8-K
    Reporting & material eventsOpen SEC filing →
  45. 4
    OwnershipOpen SEC filing →
  46. 4
    OwnershipOpen SEC filing →
  47. 4
    OwnershipOpen SEC filing →
  48. 4
    OwnershipOpen SEC filing →
  49. EFFECT
    Registration & offeringOpen SEC filing →
  50. 8-K
    Reporting & material eventsOpen SEC filing →
  51. 424B3
    Registration & offeringOpen SEC filing →
  52. 424B3
    Registration & offeringOpen SEC filing →
  53. 8-K
    Reporting & material eventsOpen SEC filing →
  54. S-1
    Registration & offeringOpen SEC filing →
  55. DEF 14A
    GovernanceOpen SEC filing →
  56. 8-K
    Reporting & material eventsOpen SEC filing →
  57. 10-Q
    Reporting & material eventsOpen SEC filing →
  58. PRE 14A
    GovernanceOpen SEC filing →
  59. 8-K
    Reporting & material eventsOpen SEC filing →
  60. 4
    OwnershipOpen SEC filing →
Evidence boundary

Only official SEC submission-index facts are automated here. The brief does not determine shell status, beneficial ownership, capitalization, legal compliance, valuation, active-trading status or transaction suitability. Those questions require the appropriate source documents and independently retained professionals.